Börsipäev 20. detsember - FNM

Rev Shark:

No Time for Pessimism
12/20/04 7:43 AM ET

The believer is happy; the doubter is wise.

-- Hungarian proverb

As we head into the holidays and kick off the final two weeks of trading, there are plenty of good reasons to doubt the ability of this market to keep moving higher. The litany of bearish arguments is painfully familiar to market participants. High oil prices, a weak dollar, a mediocre economic recovery, high levels of optimism, inflationary pressures, high stock valuations and stretched technical conditions are some of the more obvious reasons to be doubtful about this market.

The chief economist of the International Council of Shopping Centers added another reason to worry, with comments over the weekend that retail traffic and sales were below expectations, especially at the mid- to low end. It doesn't take much digging or creativity to come up with reasons to worry about the future of this market.

Obviously, there are some very good fundamental reasons for substantial doubts about how much longer the powerful rally that started back in August can last. So should we sell everything, pack up the car and go hide out at grandma's house while we wait for the inevitable collapse to occur? Should we be taking some preventative action now so we don't get caught in the doom and gloom scenario that is sure to occur sooner or later? After all, isn't the only realistic view of the market right now a negative one?

Nah. This is no time for pessimism. We have to be vigilant and watch for all those worries and concerns to kick in as some inevitably will, but for the moment the bullish believers remain in control of this market. The optimists are in firm control, and the holiday season and the end of the year only add to the upward pressure on the market.

Don't underestimate the impact of the holiday season on the market. Thin trading around holidays generally favors the bulls. The bears seem to be inclined to step aside at holidays and let the bulls control the action. When you add in the inclination of many fund managers to want to close out the year on a positive note, we have a powerful brew for keeping the upside momentum going.

Although there is good reason to expect a strong finish to the year, there are some more immediate concerns to watch for. Weakness, particularly in big-cap technology stocks, last week has left some of them in vulnerable shape. Semiconductors are struggling and don't look likely to take on their traditional leadership role. Luckily the biotechnology group has been doing well, and looks like it is in good shape to take a leadership role.

Good news from Eyetech Pharmaceuticals (EYET:Nasdaq) this morning should help the group keep things moving to the upside.

We have some old fashioned Monday morning optimism to start the week. Positive comments about eBay (EBAY:Nasdaq) and Intel (INTC:Nasdaq) are keeping the mood positive. Overseas markets are higher on strength in drug stocks and merger and acquisition rumors.

Crude oil is down slightly this morning and the dollar is mixed. Leading economic indicators are due out this morning at 10 a.m. EST.

Gary B. Smith:

Gapping Up

EYET 4.4% (announces FDA approval of Macugen), GILD 4.7% (has exposure to EYET; also, co and BMY establish a joint venture), TMIC 8% (to provide real-time antivirus scanning for MSN Hotmail customers), CATG 18% (UK court finds for CAT in Abbott drug case -- Reuters), MOSY 18% (highlighted favorably in Barron's), XING 17% (partners with Huawei Tech to supply China Unicom), DRRX 16% (co and Voyager Pharma announce acceptance of new drug application and clinical protocol by the FDA), SYBR 11%, SUPG 8% (initiated with Buy and $15 tgt at CE Unterberg), ISIS 7.5% (earns $3 mln milestone payment from Eyetech for FDA marketing clearance of Macugen), CPWR 7% (Piper nominates CPWR as its top stock pick for 2005), STEM 5.7% (Washington state considers stem cell funding -- MSNBC), GERN 5.2% (same), OSTK 4% (tgt raised to $79 at First Albany), TASR 4% (signs exclusive distribution agreement with Davidson's), SIRI 3.4% (Chrysler reports strong demand), GTW 3% (computers to be sold at Circuit City), SAP 2.6%, ABGX +2.1%.... Under $3: PACW 26% (to sell enterprise customer base), NYER 16%.

Gapping Down

MFE -5.8% (Hotmail replaces McAfee's antivirus with Trend Micro), PARS -70% (Phase III trial of Dexanabinol fails to meet endpoint), CHN -9%, GEPT -7% (announces private placement), ROXI -3.4% (completes sale of consumer software division to Sonic Solutions), QLTI -1.6% (weak on EYET's Macugen approval).
Mis selle FNM-ga nii on, et 40$ paras peaks olema?
GOOG tegi uusi lühikese perioodi tippe, turul hakkas ringlema kuulujutt, et GOOG plaanib splitti.

Mõne aja pärast uus kommentaar : "Google tahab olla nagu Berkshire Hathaway - ei ühtegi splitti" :)
Kas PFE on ikka veel pro soovitus ?
Või PARS ;) Hoidsin ise eemale
rick12, mitte "ikka veel" vaid "just nüüd"
mina igatahes votsin PFE 200 @ 24.4
osade kaupa PFE võib tõesti juba ostma hakata
veel hea näide kuidas volatiilsus optsioonihindu mõjutab
reedel kui oli kahtlus vip järjekordse maksu osas olid hinnad üleval
täna aktsiahind ei muutunud aga näiteks 25 put optsiooni hind kukkus 50%
Kas FNM proovibki nüüd g=9,8?
tänane CEO ja CFO kingasaamise uudis on FNMile pigem positiivne.
OFHEO Director Armando Falcon Jr. said in a statement that his agency had determined that Fannie Mae, the biggest player in the nation's $8 trillion mortgage market, had been left "significantly undercapitalized" because of its accounting problems.

Kuidas FNM kapitali juurde saab? Jätab dividendid maksmata?
ma arvan, et sa oled selle uudisega umbes 3 ja pool kuud hiljaks jäänud.
vaadates FNM'i viimase 3 kuu graafikut ei paista küll kuskilt välja et kasumit korrigeeritakse kolmandiku võrra väiksemaks.

noh, vaata siis 4 kuu graafikut ja näed septembris 15 punktist langust. Korrigeeritakse varasemaid kasumeid, kuid aktsiad kauplevad tuelvikukasumite järgi.
Väga kiireid arvutusi:

FNM teenis viimase 4 aastaga kasumit $23 mlrd. See oli vale raamatupidamisega ning SEC käskis seda korrigeerida $9 mlrd. võrra madalamaks ehk alandada 40%.

Ma eeldaks, et ka 2005 aasta kasumit tuleb siis 40% alandada, see teeks P/E suhtarvuks üle 14-ne. Siiani on nii konkurendid (CFC näiteks) kui ka FNM ise kaubelnud umbes P/E 9 juures. Selleks, et P/E oleks 9, peaks P (hind) olema $44.15 ...

Veidi pikemate callide kirjutamine tundub üsna atraktiivne.
Kristjan, ehk seletaksid mis alustel oletad, et 2005.a. kasum on samuti 40% väiksem?

my guess, nad kasutavad muid hedgemise meetodeid ja ikkagi maandavad lossid ära.
Nii ruttu pole nad kindlasti oma raamatupidamislikku metoodikat muutnud, seega kui korrigeerimine tuli teha tahapoole, tuleks seda ka teha ettepoole.

Ma arvan, et FNM juhtum sama nagu Norteli (NT) puhul - segamini raamatupidamist ei saada korda veel niipea. Ja aktsiahinnale see hästi ei mõju.
Kristjan, hoopis asjalikum oleks vōrrelda FNMi FREga (Freddie Mac), kes on Fannie väiksem konkurent.
9 mld on mitme aasta tasandamata lossid, mitte 2004.a. loss.
FRE 2005 P/E on ka 10 juures.

Tean, et 9 mlrd. on mitme aasta loss, seepärast kasutasingi viimase 4.a. kogukasumit ($23 mlrd.).